Clinical Trial Update: CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes an ongoing Phase 1/2 study of CAR-T cells targeting the carcinoembryonic antigen (CEA) for CEA-positive advanced solid tumo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colon Cancer
• Esophageal Cancer
• Gastric Cancer
• Lung Cancer
• Pancreatic Cancer
• Rectal Cancer

Drugs mentioned

• CEA-targeting CAR-T cell therapy

Snippet

Sponsor: Chongqing Precision Biotech Co., Ltd | Conditions: Gastric Cancer, Colon Cancer | Phase 1, Phase 2 | Status: RECRUITING